Title of article
Fibrates and coronary risk reduction
Author/Authors
George Steiner، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2005
Pages
9
From page
199
To page
207
Abstract
Many medications are currently available to correct lipoprotein abnormalities when lifestyle measures alone are not sufficient. No single agent or class of agents is able to correct all of the lipoprotein abnormalities. This paper reviews the role of one class, the fibrates, in the management of lipid disorders and summarizes the clinical trial information relating to their impact on coronary artery disease.
Keywords
Triglyceride , cholesterol , Diabetes , Fibrates , clinical trials , metabolic syndrome , coronary heart disease
Journal title
Atherosclerosis
Serial Year
2005
Journal title
Atherosclerosis
Record number
631762
Link To Document